Replies to post #24118 on Can B Corp (CANB)

[DarthYoda]

I hear you on many of your points. However, take a look at the FDA GRAS notice for dehulled hemp seed:

Fresh Hemp Foods states that dehulled hemp seed is derived from varieties of Cannabis sativa L. with low THC content, known as industrial hemp. Fresh Hemp Foods states that hemp seeds themselves do not produce THC, and that THC present in dehulled hemp seed comes from contact between the seeds and cannabinoid-containing resins from other plant parts during growth, harvest, and processing.

https://www.fda.gov/media/119427/download

The FDA has already acknowledge that some amount of hemp derived THC can be present in even a GRAS substance, which is even less regulated than a dietary supplement.

FDA needs to make a determination for the leaves and flowers or even the whole plant. Regulating only CBD is not just missing the point of the Farm Bill, it also leaves a bunch of other cannabinoids totally unregulated.

What about CBN, CBC, CBG or the 100+ other cannabinoids? These are not in any FDA approved drugs. So, the FDA has no IND preclusion to stand on when people start pumping CBN isolate into smoothies.

FDA has to think bigger than one molecule at a time. I recently saw a company advertising hemp derived THC-V isolate. This is a glimpse of the next wild west if they don't make regs for the plant, but only for CBD. THC-V is not an ingredient in any FDA approved drug.

https://www.prnewswire.com/news-releases/finally-non-psychotropic-thcv-from-hemp-is-now-available-from-a-cgmp-compliant-specialty-processor-300914154.html

[DarthYoda]

My last post left for today...and I didn't mean to over-discuss on a Friday, but that list of problems with THC is no good. You again say THC is a schedule one cannabinoid when hemp derived THC is not a schedule one cannabinoid. This is a fact. I just posted the federal amendment to the CSA.

CBD is not the only cannabinoid that functions as an antioxidant and neuroprotectant. THC does as well. You can say that THC has short term negative effects on short term memory, but we both know THC is not anywhere near as harmful as plenty of legally ingestible substances. We also know it has medical benefits, or it wouldn't be an ingredient in those FDA approved drugs you listed. Furthermore, the .3% THC that naturally occurs in hemp is so far below any level of psycho-activity, that citing such a risk comes off as a scare tactic.

Also, no FDA approved drugs contain CBD or THC derived from hemp as an ingredient. They are either synthetic or derived from marijuana.

As far as investing ahead of what you think the FDA will do, well, there is what they wanna do, and what they gotta do. The FDA were commissioned by the Farm Bill to regulate Hemp, not CBD. Are they doing that?

I don't have any beef with CANB, I just don't agree with your opinion on how the market should take shape going forward. Nothing personal. But, after the FDA has just proclaimed the IND preclusion for CBD as the whole basis for disqualifying it from food and dietary supplements, I think depriving consumers of other non-psychoactive secondary cannabinoids simply because they HAVEN'T been part of any safety studies meant for FDA approved drugs would be self-contradictory at a minimum.

There is nothing stopping any secondary cannabinoids from going into food or dietary supplements as they are not FDA drug ingredients. So if/when CBD gets a green light, the others will all legally come along for the ride. Congress passed the Farm Bill with the definition of .3% THC in it, so when it comes to passing a hemp derived CBD dietary supplement bill, congress shouldn't have an issue with .3% THC. It is not the FDA passing the legislation, so their feelings about THC wont matter. I also believe the House Bill may be amended a bit before it can fully pass.

Anyway, I'm out of posts. Have a good weekend. GL!